160 related articles for article (PubMed ID: 12153170)
1. Interdigitating dendritic cell sarcoma: a rare malignancy responsive to ABVD chemotherapy.
Olnes MJ; Nicol T; Duncan M; Bohlman M; Erlich R
Leuk Lymphoma; 2002 Apr; 43(4):817-21. PubMed ID: 12153170
[TBL] [Abstract][Full Text] [Related]
2. [Interdigitating dendritic cell sarcoma-a case report with literature review].
Gao WJ; Zhang R; Qiu HX; Shen YM; Zhang XH; Xue SL; Han Y
Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):232-4. PubMed ID: 15949268
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy.
Lee SY; Lee SR; Chang WJ; Kim HS; Kim BS; Kim IS
Korean J Hematol; 2012 Jun; 47(2):150-3. PubMed ID: 22783364
[TBL] [Abstract][Full Text] [Related]
4. [Interdigitating dendritic cell sarcoma successfully treated with ABVD therapy in which serum CEA levels correlated with disease activity].
Sakemura R; Hiraga J; Kitagawa S; Ito M; Kajiguchi T; Mizuno S
Rinsho Ketsueki; 2017; 58(4):292-297. PubMed ID: 28484155
[TBL] [Abstract][Full Text] [Related]
5. Complete Remission in Systemic Skin Interdigitating Dendritic Cell Sarcoma after ABVD Chemotherapy.
Kyogoku C; Seki M; Ogawa S; Miyamoto K; Ito Y; Kurita N; Yokoyama Y; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Fujishima F; Ichinohasama R; Nakamura S; Chiba S
J Clin Exp Hematop; 2015; 55(1):33-7. PubMed ID: 26106005
[TBL] [Abstract][Full Text] [Related]
6. [Sustained remission of blastic plasmacytoid dendritic cell neoplasm with ABVD chemotherapy].
Tanikawa S; Sakuranaka H; Chong JM; Okada Y; Takimoto M
Rinsho Ketsueki; 2012 Feb; 53(2):246-51. PubMed ID: 22450587
[TBL] [Abstract][Full Text] [Related]
7. Interdigitating dendritic cell sarcoma located in the groin: a case report and literature review.
Wang HT; Xu HY; Zhang R; Liu ZG; Zhang GJ
J Int Med Res; 2018 Nov; 46(11):4791-4799. PubMed ID: 30222020
[TBL] [Abstract][Full Text] [Related]
8. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Behringer K; Goergen H; Hitz F; Zijlstra JM; Greil R; Markova J; Sasse S; Fuchs M; Topp MS; Soekler M; Mathas S; Meissner J; Wilhelm M; Koch P; Lindemann HW; Schalk E; Semrau R; Kriz J; Vieler T; Bentz M; Lange E; Mahlberg R; Hassler A; Vogelhuber M; Hahn D; Mezger J; Krause SW; Skoetz N; Böll B; von Tresckow B; Diehl V; Hallek M; Borchmann P; Stein H; Eich H; Engert A; ; ;
Lancet; 2015 Apr; 385(9976):1418-27. PubMed ID: 25539730
[TBL] [Abstract][Full Text] [Related]
9. [Interdigitating dendritic cell sarcoma/tumor--a case report].
Miyagi T; Nagasaki A; Shinzato O; Ohshima K; Takasu N
Gan To Kagaku Ryoho; 2007 Mar; 34(3):469-71. PubMed ID: 17353646
[TBL] [Abstract][Full Text] [Related]
10. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
Connors JM; Klimo P; Adams G; Burns BF; Cooper I; Meyer RM; O'Reilly SE; Pater J; Quirt I; Sadura A; Shustik C; Skillings J; Sutcliffe S; Verma S; Yoshida S; Zee B
J Clin Oncol; 1997 Apr; 15(4):1638-45. PubMed ID: 9193364
[TBL] [Abstract][Full Text] [Related]
12. Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need?
Laskar S; Gupta T; Vimal S; Muckaden MA; Saikia TK; Pai SK; Naresh KN; Dinshaw KA
J Clin Oncol; 2004 Jan; 22(1):62-8. PubMed ID: 14657226
[TBL] [Abstract][Full Text] [Related]
13. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V
J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
Chisesi T; Bellei M; Luminari S; Montanini A; Marcheselli L; Levis A; Gobbi P; Vitolo U; Stelitano C; Pavone V; Merli F; Liberati M; Baldini L; Bordonaro R; Pesce EA; Federico M
J Clin Oncol; 2011 Nov; 29(32):4227-33. PubMed ID: 21990405
[TBL] [Abstract][Full Text] [Related]
15. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
[TBL] [Abstract][Full Text] [Related]
16. Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis.
Skoetz N; Trelle S; Rancea M; Haverkamp H; Diehl V; Engert A; Borchmann P
Lancet Oncol; 2013 Sep; 14(10):943-52. PubMed ID: 23948348
[TBL] [Abstract][Full Text] [Related]
17. Hairy cell leukemia responsive to chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD).
Patten E; Gill DP; Weiss GB
Cancer Treat Rep; 1983 Dec; 67(12):1147-8. PubMed ID: 6197166
[No Abstract] [Full Text] [Related]
18. [Disseminated interdigitating dendritic cell sarcoma].
Santarelli IM; Veltri M; Manzella DJ; Avagnina MA; Pereyra PM; Chavín HC
Medicina (B Aires); 2017; 77(3):239-241. PubMed ID: 28643685
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Canellos GP; Anderson JR; Propert KJ; Nissen N; Cooper MR; Henderson ES; Green MR; Gottlieb A; Peterson BA
N Engl J Med; 1992 Nov; 327(21):1478-84. PubMed ID: 1383821
[TBL] [Abstract][Full Text] [Related]
20. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
